AIMP1 and non-Hodgkin lymphoma: The study also examined EMAP II expression on peripheral blood cells and the prognosis of NHL by evaluating EMAP II expression clinical data and identified that percentages of EMAP II+CD16+ were elevated in NHL patients with hepatomegaly or splenomegaly.